The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000152.4(GAA):c.573C>A (p.Tyr191Ter)

CA16041885

370276 (ClinVar)

Gene: GAA
Condition: glycogen storage disease II
Inheritance Mode: Autosomal recessive inheritance
UUID: 08e9886c-b096-4ec6-ac73-d3614d005d8a
Approved on: 2020-05-19
Published on: 2020-06-03

HGVS expressions

NM_000152.4:c.573C>A
NM_000152.4(GAA):c.573C>A (p.Tyr191Ter)
NM_000152.3:c.573C>A
NM_001079803.1:c.573C>A
NM_001079804.1:c.573C>A
NM_001079803.2:c.573C>A
NM_001079804.2:c.573C>A
NM_000152.5:c.573C>A
NM_001079803.3:c.573C>A
NM_001079804.3:c.573C>A
ENST00000302262.7:c.573C>A
ENST00000390015.7:c.573C>A
ENST00000570803.5:c.573C>A
ENST00000577106.5:c.573C>A
NC_000017.11:g.80105775C>A
CM000679.2:g.80105775C>A
NC_000017.10:g.78079574C>A
CM000679.1:g.78079574C>A
NC_000017.9:g.75694169C>A
NG_009822.1:g.9220C>A
More

Pathogenic

Met criteria codes 3
PVS1 PP4 PM2
Not Met criteria codes 1
PM3

Evidence Links 3

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Lysosomal Diseases VCEP
This variant, c.573C>A (p.Tyr191Ter), is a nonsense variant that is predicted to result in nonsense-mediated decay and lack of gene product, meeting PVS1. The highest population minor allele frequency in gnomAD v2.1.1 is 0.00003 in the Latino population, meeting PM2. Two patients meeting the ClinGen LSD VCEP's specifications for PP4 have been reported. These patients are compound heterozygous for the variant and either c.2173C>T (p.Arg725Trp) (PMID 18505979), or c.2646+2T>A (PMID 11738358). However, in both cases, the in trans data from these patients will be used in the classification of the other variant and was not included here in order to avoid a circular argument. Additional patients have been reported but were not included because the residual GAA activity was not reported and therefore PP4 cannot be assessed (PMIDs 25998610, 27711114, 30022036). There is a ClinVar entry for this variant (Variation ID: 370276; 1 star review status) with one submitter classifying the variant as likely pathogenic. In summary, this variant meets the criteria to be classified as pathogenic for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: PVS1, PM2, PP4.
Met criteria codes
PVS1
This variant is predicted to result in a premature stop codon that is detected by nonsense mediated decay resulting in lack of gene product, meeting PVS1.
PP4
Two individuals have been reported with this variant and <30% normal GAA activity in cultured fibroblasts (PMIDs 11738358, 18505979). This meets the ClinGen LSD VCEP's specifications for PP4.

PM2
The highest population minor allele frequency in gnomAD v2.1.1 is 0.00003 (Latino) which is lower than the ClinGen LSD VCEP threshold (<0.001) for PM2, meeting this criterion.
Not Met criteria codes
PM3
Two patients meeting the ClinGen LSD VCEP's specifications for PP4 have been reported. These patients are compound heterozygous for the variant and either c.2173C>T (p.Arg725Trp) (PMID 18505979), or c.2646+2T>A (PMID 11738358). However, in both cases, the in trans data from these patients will be used in the classification of the other variant and was not included here in order to avoid a circular argument. Additional patients have been reported but were not included because the residual GAA activity was not reported and therefore PP4 cannot be assessed (PMIDs 25998610, 27711114, 30022036).

Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.